Clarifying Cannabis From THCA Loopholes to Schedule III Shifts

Clarifying Cannabis From THCA Loopholes to Schedule III Shifts

Author: Cannabis Radio June 17, 2026 Duration: 40:52

Dr. Priyanka Sharma, co-CEO of Kazmira Therapeutics and fellow co-CEO Pulak Sharma, cut through the confusion surrounding the rapidly evolving cannabis and hemp sectors. She clarifies the critical distinction between THCA—the non-intoxicating precursor that converts to THC upon heating—and delta-9 THC, noting that current marketing often masks the potential intoxicating effects of heated THCA products.

Dr. Sharma also unpacks the implications of the Schedule III reclassification, explaining why it creates a distinct "two-lane system" for medical cannabis versus industrial hemp rather than a blanket regulatory change.



Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

There’s a lot more to the cannabis industry than what grows in the field. Blunt Business, from Cannabis Radio, digs into the complex reality of building and running a company in this fast-moving space. We’re talking about the real work behind the scenes-supply chain logistics, regulatory hurdles, branding in a crowded market, and managing teams in a unique cultural environment. Each episode brings together voices who are actually doing the job, from executives steering multi-state operations to entrepreneurs who just opened their first dispensary. You’ll hear candid roundtable discussions where strategies are debated, and interviews that get into the specifics of leadership and finance without the hype. This isn’t about advocacy or culture; it’s a practical look at the mechanics of a profitable, high-stakes business. Tune in for a podcast that cuts through the smoke and offers tangible insights you can apply, whether you’re an investor, a manager, or building your own venture from the ground up.
Author: Language: English Episodes: 50

Blunt Business
Podcast Episodes
How Rescheduling Could Transform Cannabis Economics and Brain Health [not-audio_url] [/not-audio_url]

Duration: 21:27
This week we explore the dual impact of cannabis legalisation and rescheduling—focusing on both the massive financial implications for the industry and emerging scientific research on health benefits.The $2 Billion Tax W…
Back to Business: Navigating the 2026 Cannabis Frontier [not-audio_url] [/not-audio_url]

Duration: 24:00
After a much-needed hiatus following eight years of consistent broadcasting, Blunt Business has returned in 2026 by reaffirming the show's commitment to raw, unfiltered industry commentary.This "re-launch" episode marks…
President Trump Signs Landmark Cannabis Rescheduling Order [not-audio_url] [/not-audio_url]

Duration: 19:49
In what is being hailed as a "watershed moment" for the cannabis industry, President Trump has officially signed an executive order to move cannabis from Schedule 1 to Schedule 3 of the Controlled Substances Act. This hi…